Top > Find a Doctor > Masahiko Tanabe

Masahiko Tanabe

Masahiko  Tanabe

Breast and Endocrine Surgery


M.D. , Ph.D.


surgery on primary breast cancer, systemic treatment on metastatic breast cancer

Research Interests

epigenetic change which is critical for breast cancer development, transcriptional regulation of estrogen receptor alpha (ERα)in breast cancer




Year Institution Degree
1998 The University of Tokyo, Faculty of Medicine M.D.
2009 The University of Tokyo, Graduate School of Medicine Ph.D.
Years attended Institution Discipline
1998 The University of Tokyo Hospital Internship (surgery departments)
1999 Takeda General Hospital (Aizuwakamatsu) Resident surgeon
2002 Cancer Institute Hospital Resident surgeon for breast cancer
Appointments and positions
Years Institution Titles
2013 Department of breast oncology, Juntendo University Hospital Associate professor
2016 Department of breast surgical oncology, Kyoundo Hospital Director
2018 Department of breast and endocrine surgery, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo Lecturer
Board Certifications
Year Certifications
2006 Japan Surgical Society Board Certified Surgeon
2015 Japanese Society of Breast Cancer Board Certified Surgeon
Selected Publications
  • Tanabe M, Fukuda T, Ito Y. The position of combination chemotherapy with mitomycin C and methotrexate in the treatment of metastatic breast cancer - especially triple negative breast cancer. Oncomedicine, 2017; 2:126-131.
  • Tanabe M, Fujiyama S, and Horimoto Y. Developmentally regulated GTP binding protein 2 (DRG2) and Nup107 are associated with epigenetic regulation via H2A.Z on promoter regions of specific genes in MCF7 breast cancer cells. Journal of Clinical Epigenetics 2016: Volume 2, Issue 4(21)
  • Tanabe M, Iwase T, Okumura Y, Yoshida A, Masuda N, Nakatsukasa K, Shien T, Tanaka S, Komoike Y, Taguchi T, Arima N, Nishimura R, Inaji H, Ishitobi M. Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society. Local recurrence risk after previous salvage mastectomy. Eur J Surg Oncol. 2016 Jul;42(7):980-5.
Academic Societies
  • Japan Surgical Society
  • The Japanese Breast Cancer Society
  • The Japanese Society for Familial Tumors
  • The Japan Society of Human Genetics
  • Japanese Society of Medical Oncology
  • Japan Oncoplastic Breast Surgery Society
  • The Japan Society of Ultrasonics in Medicine
  • Japanese Society for Genetic Counseling
  • Japanese Society for Palliative Medicine
Editorial Boards
  • Breast cancer
  • Journal of Clinical Epigenetics
  • Cancer Studies and Molecular Medicine

page top